Author

A. Scheiter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Organism:human· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Cigliano· 1 shared A. Coluccio· 1 shared A. Teufel· 1 shared C. Brochhausen· 1 shared D. Calvisi· 1 shared D. Song· 1 shared F. Dombrowski· 1 shared G.-S. Feng· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Cigliano

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of CD133+ Intercellsomes in Intercellular Communication to Offset Intracellular Signal Deficit

K. Kaneko, Y. Liang, Q. Liu, S. Zhang, A. Scheiter, D. Song, G.-S. Feng

The paper identifies CD133+ intercellsomes as a mechanism for intercellular communication to compensate for intracellular signal deficits in stress conditions.

bioRxiv · May 16, 2022Cancer Biology

RASSF1A independence and early Galectin-1 upregulation in PIK3CA induced hepatocarcinogenesis: new therapeutic venues

A. Scheiter, K. Evert, L. Reibenspies, A. Cigliano, K. Annweiler, K. Mueller, L.-M.-G. Poehmerer, T. Itzel, S. Materna-Reichelt, A. Coluccio, K. Honarnejad, A. Teufel, C. Brochhausen, F. Dombrowski, X. Chen, , K. Utpatel

This study shows that PIK3CA mutations drive hepatocarcinogenesis independently of RASSF1A status, with early Galectin-1 upregulation and synergistic therapeutic effects of PIK3CA and Galectin-1 inhibitors.

bioRxiv · Jun 15, 2021Pathology